Research and Development - The company has maintained a high R&D expense ratio of over 30% for the past three years, indicating a strong commitment to technological innovation and product advancement[9]. - As of December 31, 2023, the company holds a total of 130 authorized patents, including 11 U.S. patents, and has registered over 100 software copyrights[9]. - R&D investment amounted to ¥207,178,497.22 in 2023, a 67.70% increase from ¥123,539,145.58 in 2022, representing 43.38% of total revenue[132]. - R&D personnel increased to 416, a 67.74% rise from 248 in the previous year, with R&D personnel now constituting 83.20% of the workforce[129]. - The company is currently developing the DFM tool platform to enhance manufacturing yield, aiming for significant performance advantages in EDA tools[124]. - The DFT design automation tool is in progress, targeting MCU, AI, GPU, and 5G baseband applications, with a focus on improving design quality and cost efficiency[124]. - The Advanced PCM project aims to replace traditional monitoring solutions, enhancing efficiency in mass production with comprehensive electrical monitoring[124]. - The semiconductor general data analysis software (DE-G) V3.0 has been completed, adding critical statistical functions to improve reliability analysis for semiconductor engineers[126]. - The integrated circuit yield management system (DE-YMS) V2.0 is ongoing, enhancing system performance and real-time monitoring capabilities for testing results[126]. - The AI technology research in semiconductor big data analysis is ongoing, aiming to support machine learning applications and improve yield control[126]. - The company plans to expand its product monitoring solutions to cover the entire lifecycle of chips, enhancing performance and health monitoring capabilities[126]. - The testing chip standard cell library development is in progress, aimed at standardizing design processes and improving efficiency and quality[126]. Corporate Governance - The company has established a sound corporate governance structure, including a strategic decision-making committee, nomination committee, audit committee, and remuneration and assessment committee[21]. - The company maintains independent legal person status and has ownership or usage rights to key production systems, R&D equipment, trademarks, patents, and non-patented technologies[20]. - There are no significant discrepancies between the company's governance practices and the regulations set forth by the China Securities Regulatory Commission[19]. - The company has implemented a robust internal audit system to ensure compliance and oversight[17]. - The company has invited witnessing lawyers to attend shareholder meetings to ensure the rights of minority shareholders are upheld[15]. - The company has a total of three supervisors, including one employee representative, in compliance with legal requirements[16]. - The company’s board of directors has been actively involved in governance and operational decision-making, ensuring timely and effective resolutions[74]. - The company has maintained compliance with relevant laws and regulations, ensuring sound corporate governance practices[74]. Financial Performance - Total revenue grew by 34.31% year-on-year, while operating costs increased by 65.46% due to sustained growth in testing equipment business[144]. - The company reported a revenue increase of 15% year-over-year, reaching $1.2 billion in Q3 2023[183]. - User data showed a growth of 25% in active users, totaling 5 million by the end of the quarter[183]. - The gross margin improved to 45%, up from 40% in the previous year, due to cost optimization strategies[183]. - The company plans to continue expanding its market presence and investing in new technologies[162]. Shareholder Relations - The company plans to distribute a cash dividend of 4.40 RMB per 10 shares, totaling 88 million RMB, based on a total share capital of 200 million shares as of December 31, 2023[52]. - The company distributed a cash dividend of 4.40 CNY per 10 shares, totaling 88,000,000 CNY, which represents 100% of the distributable profit of 150,207,616.03 CNY[103]. - The company has committed to not transferring or managing the newly issued shares from the capital increase for three years starting from September 28, 2020, in compliance with regulatory requirements[184]. - The company has fulfilled its share transfer commitment as of June 25, 2021, with the lock-up period ending on September 28, 2023[184]. - The company will report any share reduction plans to the stock exchange 15 trading days prior to the first sale[187]. - The company will ensure that any profits from share reductions that violate commitments will be returned to the company[187]. Employee Management - The total number of employees at the end of the reporting period was 500, with 416 being technical staff[79]. - The company has established a comprehensive internal training system to enhance employee skills and competencies, aligning with its long-term development strategy[102]. - The company’s 2023 stock incentive plan was approved, aiming to enhance employee motivation and retention[85]. - The company emphasizes the importance of employee health and safety, providing annual health check-ups and supplementary commercial insurance[121]. Market Strategy - The company is expanding its market presence in Southeast Asia, targeting a 20% market share by 2025[183]. - A strategic acquisition of a local tech firm was completed, expected to contribute an additional $200 million in annual revenue[183]. - The company plans to implement a new customer loyalty program aimed at increasing retention rates by 15%[183]. Risk Management - The company recognizes the risk of high customer concentration and is taking steps to mitigate this risk through diversified client engagement[3]. - The company is focused on improving internal controls and management efficiency to adapt to its expanding business scale and complexity[5]. - The company has established a comprehensive business ethics management policy to reduce legal risks and ensure compliance with applicable laws[119]. Sustainability and Social Responsibility - The company is committed to sustainability, with a goal to reduce carbon emissions by 30% by 2025[183]. - The company has donated over 1 million yuan to the Honghui Education Development Foundation to support rural education[118]. - The company focuses on responsible supply chain management, evaluating suppliers based on compliance, quality, and labor rights[121].

天健审〔2024〕2247 号 杭州广立微电子股份有限公司全体股东： 目 录 | 一、审计报告……………………………………………………… | 第 | 1—5 | 页 | | --- | --- | --- | --- | | 二、财务报表……………………………………………………… | 第 | 6—13 | 页 | | （一）合并资产负债表…………………………………………… | | 第 6 | 页 | | （二）母公司资产负债表………………………………………… | | 第 7 | 页 | | （三）合并利润表………………………………………………… | | 第 8 | 页 | | （四）母公司利润表……………………………………………… | | 第 9 | 页 | | （五）合并现金流量表……………………………………………第 | | 10 | 页 | | （六）母公司现金流量表…………………………………………第 | | 11 | 页 | | （七）合并所有者权益变动表……………………………………第 | | 12 | 页 | | （八）母公司所有者权益变动表…………………………………第 | | 13 | 页 | | ...

根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等 要求，杭州广立微电子股份有限公司（以下简称"公司"）董事会就现任独立董 事在的独立性情况进行评估并出具如下专项意见： 经核查，独立董事朱茶芬女士、杨华中先生、刘军先生的任职经历以及签 署的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，也未 在公司主要股东公司担任任何职务，与公司以及主要股东之间不存在利害关系 或其他可能妨碍其进行独立客观判断的关系，因此，公司董事会认为上述独立 董事符合《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》中对独立董事独立性的相关要求。 杭州广立微电子股份有限公司 杭州广立微电子股份有限公司董事会 2024 年 4 月 19 日 关于独立董事独立性自查情况的专项报告 ...

杭州广立微电子股份有限公司 2023 年度董事会工作报告 （一）主营业务经营情况 2023 年度，集成电路产业整体处于下行周期内，集成电路设计公司及晶圆厂整 体资本支出较往年有所缩减。公司在此期间积极调整市场推广战略，着眼于中长期 市场布局，加大 EDA 软件、大数据软件及测试设备产品的研发投入，并取得了较好 的成果： 1）将成品率提升业务从工艺开发向量产应用推广。公司研发了先进的量产监控 方案（Advanced PCM），并已经在多家晶圆厂试用并取得了客户广泛的好评； 2）通过"自主研发为主，外延并购为辅"加速拓展 EDA 软件品类。公司报告期 内推出了可制造性设计（DFM）相关软件；通过并购上海亿瑞芯科技有限公司将可测 试性设计（DFT）解决方案融入公司的良率提升整体方案中；此外，公司积极与 EDA 合作伙伴共同拓展产业工具链，投资设立了浙江亿方杭创科技有限公司，研发全局 良率和产品性能的签核系统，致力打造"国家级 EDA 签核中心"； 3）公司抓住集成电路产业的国产替代浪潮，加大测试设备产品的推广进行 WAT 市场占有率布局，相较 2022 年测试设备硬件营收增长 57.58%； 4）公司自主研发的半导 ...

证券代码：301095 证券简称：广立微 公告编号：2024-024 杭州广立微电子股份有限公司 第二届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 监事会会议召开情况 杭州广立微电子股份有限公司（以下简称"公司"）第二届监事会第三次会 议于 2024 年 4 月 18 日（星期四）在浙江省杭州市余杭区五常街道联创街 188 号 A1 号楼 4 楼会议室召开，会议通知已于 2024 年 4 月 8 日通过书面、邮件及其他 通讯方式送达全体监事。本次会议应出席监事 3 名，实际出席监事 3 名。会议由 监事会主席潘伟伟女士召集和主持，董事会秘书、财务总监陆春龙先生列席会议。 本次会议的召集和召开符合《中华人民共和国公司法》等有关法律、行政法 规、部门规章和《公司章程》的规定，形成的决议合法有效。 二、 监事会会议审议情况 经与会监事审议，一致通过以下决议： （一） 审议通过《关于<2023 年度监事会工作报告>的议案》 具体内容详见公司同日披露在巨潮资讯网（www.cninfo.com.cn）上的《2023 年度监事会工作报告》 ...

杭州广立微电子股份有限公司 董事会审计委员会对会计师事务所 2023 年度履职情况 评估及履行监督职责情况的报告 (一) 会计师事务所基本情况 1. 基本信息 | 事务所名称 | 天健会计师事务所（特殊普通合伙） | | | | | --- | --- | --- | --- | --- | | 成立日期 2011 | 年 月 日 7 18 | 组织形式 | | 特殊普通合伙 | | 注册地址 | 浙江省杭州市西湖区灵隐街道西溪路 | 128 | 号 | | | 首席合伙人 王国海 | | 上年末合伙人数量 | | 238 人 | | 上年末执业人 | 注册会计师 | | | 人 2,272 | | 员数量 | 签署过证券服务业务审计报告的注册会计师 | | | 人 836 | | 年（经审 2023 | 业务收入总额 | 34.83 | 亿元 | | | 计）业务收入 | 审计业务收入 | 30.99 | 亿元 | | | | 证券业务收入 | 18.40 | 亿元 | | | | 客户家数 | | 675 家 | | | | 审计收费总额 | 6.63 | 亿元 | | | 2023 年上市公 | | | ...

Financial Performance - The company achieved operating revenue of CNY 43.90 million in Q1 2024, representing a year-on-year growth of 100.65%[28]. - The company's revenue for Q1 2024 was ¥43,904,608.50, representing a 100.65% increase compared to ¥21,881,595.72 in the same period last year[34]. - Total revenue for the period reached CNY 43,904,608.50, a significant increase from CNY 21,881,595.72 in the previous period, representing a growth of approximately 100.5%[73]. - Operating profit for the period was CNY -31,436,512.46, compared to CNY 2,213,791.94 in the previous period, indicating a decline in profitability[74]. - Net profit for the period was CNY -21,620,340.48, a decrease from CNY 4,031,966.79 in the previous period, reflecting a negative shift in financial performance[74]. - The net loss attributable to shareholders for Q1 2024 was ¥22,898,502.48, a decrease of 667.92% from a profit of ¥4,031,966.79 in the previous year[34]. - The company's basic earnings per share for Q1 2024 was -¥0.11, a decline of 650.00% from ¥0.02 in the same period last year[34]. - The company reported a basic earnings per share of CNY -0.11, compared to CNY 0.02 in the previous period, indicating a significant drop in earnings[74]. Operating Costs and Expenses - Operating costs for the same period were CNY 13.77 million, an increase of 451.47% compared to the previous year[15]. - R&D expenses amounted to CNY 71.73 million, reflecting a 72.18% increase year-on-year due to heightened investment in research and development[17]. - The company's management expenses for the period were ¥10,664,800.00, reflecting a 32.16% increase compared to the same period last year[44]. - The company's cash paid to employees rose significantly to $93,562,737.44 from $58,817,855.44[77]. - Cash paid for other operating activities increased to $20,472,639.48 from $8,713,143.24[77]. Cash Flow - The net cash flow from operating activities was CNY -84.13 million, a decline of 86.16% compared to the same period last year, primarily due to reduced sales collections and increased personnel expenses[18]. - The net cash flow from operating activities was -¥84,126,640.15, which is an 86.16% decline compared to -¥45,191,259.17 in the prior year[34]. - Operating cash inflow totaled $100,593,302.42, down 41% from $170,231,518.02 in the previous period[77]. - Cash outflow from operating activities was $184,719,942.57, compared to $215,422,777.19 in the prior period[77]. - Cash received from tax refunds increased to $8,691,087.92 from $3,500,095.93[77]. - Cash paid for interest, dividends, or profit distribution was $438,826.61, slightly up from $401,265.56[78]. Assets and Liabilities - The total assets at the end of Q1 2024 were ¥3,463,314,494.27, down 2.31% from ¥3,545,378,296.20 at the end of the previous year[34]. - Total current assets decreased to CNY 3,046,614,759.45 from CNY 3,154,231,797.08, a decline of about 3.4%[73]. - The total liabilities and equity amounted to CNY 3,463,314,494.27, down from CNY 3,545,378,296.20, indicating a reduction of approximately 2.3%[73]. - The company's cash and cash equivalents decreased to CNY 2,392,978,548.70 from CNY 2,494,750,788.06, a decline of about 4.1%[73]. - The balance of short-term borrowings at the end of the period was CNY 2.00 million, resulting from the addition of small loans[12]. - The balance of employee compensation payable decreased by 51.48% to CNY 28.40 million, primarily due to year-end bonus payments[13]. - Other current liabilities decreased by 70.45% to CNY 28,300, mainly due to a reduction in pending sales tax amounts[14]. Investments and Equity - Long-term equity investments increased by 30.84% to CNY 38.98 million, attributed to additional investments in a Korean joint venture during the reporting period[11]. - Other non-current assets rose by 117.96% to CNY 4.48 million, mainly due to increased prepayments for equipment[12]. - The deferred tax assets increased by 60.85% to ¥27,310,298.87, primarily due to the recognition of deferred tax assets based on taxable income[39]. - The minority interests increased by 47.64% to ¥3,961,200.00, due to the increase in the equity of minority shareholders in the subsidiary[42]. - The total equity attributable to shareholders of the parent company was CNY 3,242,179,867.99, slightly down from CNY 3,254,831,414.47[73]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,184[48]. - The largest shareholder, Hangzhou Guangli Micro Equity Investment Co., Ltd., holds 16.62% of shares, totaling 33,242,812 shares[48]. - The company plans to repurchase shares at a price not exceeding RMB 80.00 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's approval[51]. - The repurchase period is set for up to 12 months from the board's approval date[52]. - The company has not reported any changes in the top 10 shareholders participating in margin financing and securities lending[49]. Seasonal Trends - The company's main business revenue shows seasonal characteristics, with the first half of the year accounting for 26.67% of total revenue in 2023[53]. - The first quarter of 2023 accounted for 4.58% of the total revenue, indicating a trend of increasing revenue concentration in the second half of the year[53]. - The company’s financial performance may exhibit significant seasonal fluctuations, impacting annual profit predictions based on quarterly reports[53].

杭州广立微电子股份有限公司 独立董事 2023 年度述职报告 （朱茶芬） 本人朱茶芬，作为杭州广立微电子股份有限公司（以下简称"公司"）的第一 届、第二届董事会独立董事，2023 年度严格按照《中华人民共和国公司法》(以下简 称《公司法》)、《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规 则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等相关法律法规以及公司《独立董事工作细则》《公司章程》的规定和要求，切实履 行独立董事诚信勤勉的职责和义务，积极出席相关会议，认真审议董事会各项议案， 参与公司经营发展的讨论，充分发挥独立董事的作用，对公司相关事项发表了公正、 客观的独立意见，切实维护了公司的规范化运作及全体股东尤其是中小股东的合法 权益。现将 2023 年度本人履行独立董事职责的工作情况报告如下： 一、 独立董事基本情况 朱茶芬，1980 年 4 月出生，上海财经大学会计学博士，浙江大学工商管理博士 后，香港城市大学访问学者，拥有中国注册会计师非执业会员证，上市公司独立董 事资格证，浙江省高级专业技术资格证书。现任浙江大学管理学院财会系副教授， 兼任浙江大学财会研 ...

（一）日常关联交易概述 公司及子公司因日常经营发展需要，计划在 2024 年度与泰特斯股份有限公司（以 下简称"泰特斯"）、武汉微泰电子有限公司（以下简称"武汉微泰"）发生关联交易， 预计 2024 年度与关联方发生日常关联交易额度不超过 15,300 万元。公司预计 2023 年 度与武汉微泰、杭州捷创电子有限公司发生日常关联交易 3,000.00 万元，实际发生金额 为 1,898.35 万元。 中国国际金融股份有限公司 关于杭州广立微电子股份有限公司 2023 年度日常关联交易执行情况及 2024 年度预计日常关联交易 的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为杭州广 立微电子股份有限公司（以下简称"广立微"或"公司"）持续督导的保荐机构，根据 《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》和《深圳 证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《深圳证券交 易所上市公司自律监管指引第 13 号——保荐业务》等有关法律法规和规范性文件的要 求，对公司 2023 年度日常关联交易执行情况及 2024 年度预计日常关联交易事项进 ...

证券代码：301095 证券简称：广立微 公告编号：2024-013 杭州广立微电子股份有限公司 第二届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 董事会会议召开情况 杭州广立微电子股份有限公司（以下简称"公司"）第二届董事会第四次会 议于 2024 年 4 月 18 日（星期四）在杭州市余杭区五常街道联创街 188 号 A1 号 楼 4 楼会议室以现场结合通讯方式召开。会议通知已于 2024 年 4 月 8 日通过书 面、邮件及其他通讯方式送达全体董事，全体董事确认已收到本次董事会会议的 会议通知。本次会议应出席董事 7 人，实际出席董事 7 人，并以通讯方式出席会 议。本次会议由董事长郑勇军先生主持，公司监事、高级管理人员列席了本次会 议。 本次会议的召集和召开符合有关法律、行政法规、部门规章和《公司章程》 的规定，形成的决议合法有效。 二、 董事会会议审议情况 经与会董事审议表决，一致通过以下决议： （一）审议通过《关于<2023 年度总经理工作报告>的议案》 《2023 年度总经理工作报告》对公司业绩完成情况、产品与 ...